Revised forecast
Fiscal year ending September 2026 · Full yearPrevious forecast published 6 November 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Operating profit and ordinary profit are expected to exceed the forecast due to the comprehensive medical support business expanding beyond expectations, while net income attributable to owners of the parent is expected to fall below the forecast because ¥2,142 million in impairment losses was recognized as an extraordinary loss.
Impairment loss on fixed assets: ¥2,142 million (West Japan area: ¥1,636 million; East Japan area: ¥506 million)
| Item | Details |
|---|---|
| Net Sales | ¥51,700 million → ¥50,000 million（-3.3%） |
| Operating profit | ¥3,800 million → ¥4,000 million（+5.3%） |
| Ordinary income | ¥3,300 million → ¥4,000 million（+21.2%） |
| Profit attributable to owners of the parent | ¥2,100 million → ¥1,250 million（-40.5%） |
| Net income per share | 21.53 yen/sen → 12.77 yen/sen |
| Fiscal Period Covered | Fiscal year ending September 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 6 November 2025 |
| Previous-period results | Revenue: ¥49,174 million; EBITDA: ¥8,966 million; operating profit: ¥6,162 million; ordinary profit: ¥6,343 million; net income attributable to owners of the parent: ¥3,660 million; earnings per share: ¥37.52 (fiscal year ended September 2025) |
| Reason for the revision | Operating profit and ordinary profit are expected to exceed the forecast due to the comprehensive medical support business expanding beyond expectations, while net income attributable to owners of the parent is expected to fall below the forecast because ¥2,142 million in impairment losses was recognized as an extraordinary loss. |
| Details and amount of extraordinary loss | Impairment loss on fixed assets: ¥2,142 million (West Japan area: ¥1,636 million; East Japan area: ¥506 million) |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Operating profit and ordinary profit are expected to exceed the previous forecast, mainly because the comprehensive medical support business expanded beyond expectations. However, net income attributable to owners of the parent is expected to fall below the previous forecast because ¥2,142 million in impairment losses on certain facilities was recognized as an extraordinary loss.